Similarly, in BACA2-deficient breast cancer cells, WRN helicase protects against the over-degradation of stalled forks in BRCA2-deficient cancer cells by inhibiting the activity of MRE11 and EXO1 nuclease on the degenerating forks. This evidence concerns the gene WRN and cancer.